Omeprazole induction of cytochrome P-450IA2 : the importance of selecting the appropriate human modelWATKINS, P. B.Hepatology (Baltimore, Md.). 1993, Vol 17, Num 4, pp 748-750, issn 0270-9139Article

Breath tests as noninvasive assays of P450sWATKINS, P. B.Methods in enzymology. 1991, Vol 206, pp 517-522, issn 0076-6879Article

Drug metabolism by cytochromes P450 in the liver and small bowelWATKINS, P. B.Gastroenterology clinics of North America. 1992, Vol 21, Num 3, pp 511-526, issn 0889-8553Article

Descending paralysis resulting from occult Wound botulismRAPOPORT, S; WATKINS, P. B.Annals of neurology. 1984, Vol 16, Num 3, pp 359-361, issn 0364-5134Article

Ethanol and production of the hepatotoxic metabolite of acetaminophen in healthy adultsTHUMMEL, K. E; SLATTERY, J. T; RO, H et al.Clinical pharmacology and therapeutics. 2000, Vol 67, Num 6, pp 591-599, issn 0009-9236Article

Steady-state pharmacokinetics of delavirdine in HIV-positive patients: Effect on erythromycin breath testCHENG, C.-L; SMITH, D. E; CARVER, P. L et al.Clinical pharmacology and therapeutics. 1997, Vol 61, Num 5, pp 531-543, issn 0009-9236Article

The erythromycin breath test selectively measures P450IIIA in patients with severe liver diseaseLOWN, K; KOLARS, J; TURGEON, K et al.Clinical pharmacology and therapeutics. 1992, Vol 51, Num 3, pp 229-238, issn 0009-9236Article

Differential regulation of liver P-450III cytochromes in choline-deficient rats : implications for the erythromycin breath test as a parameter of liver functionKOLARS, J. C; MURRAY, S. A; PETERS, K. M et al.Hepatology (Baltimore, Md.). 1990, Vol 12, Num 6, pp 1371-1378, issn 0270-9139, 8 p.Article

Identification of a human liver cytochome P-450 homologous to the major isosafrole-inducible cytochrome P-450 in the ratWRIGHTON, S. A; CAMPANILE, C; GUZELIAN, P. S et al.Molecular pharmacology. 1986, Vol 29, Num 4, pp 405-410, issn 0026-895XArticle

Identification of the cytochrome P-450 induced by macrolide antibiotics in rat liver as the glucocorticoid responsive cytochrome P-450_pWRIGHTON, S. A; MAUREL, P; SCHUETZ, E. G et al.Biochemistry (Easton). 1985, Vol 24, Num 9, pp 2171-2178, issn 0006-2960Article

Predicting drug interactions in vivo from experiments in vitro : Human studies with paclitaxel and ketoconazoleJAMIS-DOW, C. A; PEARL, M. L; WATKINS, P. B et al.American journal of clinical oncology. 1997, Vol 20, Num 6, pp 592-599, issn 0277-3732Article

Erythromycin breath test and clinical transplantationWATKINS, P. B.Therapeutic drug monitoring. 1996, Vol 18, Num 4, pp 368-371, issn 0163-4356Conference Paper

Genetic predisposition to drug-induced liver diseaseFONTANA, R. J; WATKINS, P. B.Gastroenterology clinics of North America. 1995, Vol 24, Num 4, issn 0889-8553, VIII, 811-838 [29 p.]Article

The erythromycin breath test predicts the clearance of midazolamLOWN, K. S; THUMMEL, K. E; BENEDICT, P. E et al.Clinical pharmacology and therapeutics. 1995, Vol 57, Num 1, pp 16-24, issn 0009-9236Article

Aflatoxin B1-adduct formation in rat and human small Bowel enterocytesKOLARS, J. C; BENEDICT, P; SCHMIEDLIN-REN, P et al.Gastroenterology (New York, NY. 1943). 1994, Vol 106, Num 2, pp 433-439, issn 0016-5085Article

Prediction of interpatient and intrapatient variation in OG 37-325 dosing requirements by the erythromycin breath test : a prospective study in renal transplant recipientsTURGEON, D. K; LEICHTMAN, A. B; BLAKE, D. S et al.Transplantation. 1994, Vol 57, Num 12, pp 1736-1741, issn 0041-1337Article

Comparison of urinary 6-β-cortisol and the erythromycin breath test as measures of hepatic P450IIIA (CYP3A) activityWATKINS, P. B; TURGEON, D. K; SAENGER, P et al.Clinical pharmacology and therapeutics. 1992, Vol 52, Num 3, pp 265-273, issn 0009-9236Article

The erythromycin breath test as a predictor of cyclosporine blood levelsWATKINS, P. B; HAMILTON, T. A; ANNESLEY, T. M et al.Clinical pharmacology and therapeutics. 1990, Vol 48, Num 2, pp 120-129, issn 0009-9236, 10 p.Article

Case Definition and Phenotype Standardization in Drug-Induced Liver InjuryAITHAL, G. P; WATKINS, P. B; BJORNSSON, E et al.Clinical pharmacology and therapeutics. 2011, Vol 89, Num 6, pp 806-815, issn 0009-9236, 10 p.Article

Cytochrome P-450 1A1 expression in human small bowel : Interindividual variation and inhibition by ketoconazolePAINE, M. F; SCHMIEDLIN-REN, P; WATKINS, P. B et al.Drug metabolism and disposition. 1999, Vol 27, Num 3, pp 360-364, issn 0090-9556Article

Cultured adult rat jejunal explants as a model for studying regulation of CYP3ASCHMIEDLIN-REN, P; BENEDICT, P. E; DOBBINS, W. O et al.Biochemical pharmacology. 1993, Vol 46, Num 5, pp 905-918, issn 0006-2952Article

Identification of rifampin-inducible P450IIIA4 (CYP3A4) in human small bowel enterocytesKOLARS, J. C; SCHMIEDLIN-REN, P; SCHUETZ, J. D et al.The Journal of clinical investigation. 1992, Vol 90, Num 5, pp 1871-1878, issn 0021-9738Article

Identification of a polymorphically expressed member of the human cytochrome P-450III familyWRIGHTON, S. A; RING, B. J; WATKINS, P. B et al.Molecular pharmacology. 1989, Vol 36, Num 1, pp 97-105, issn 0026-895XArticle

Purification of a human liver cytochrome P-450 immunochemically related to several cytochromes P-450 purified from untreated ratsWRIGHTON, S. A; THOMAS, P. E; WILLIS, P et al.The Journal of clinical investigation. 1987, Vol 80, Num 4, pp 1017-1022, issn 0021-9738Article

Complete cDNA sequence of a cytochrome P-450 inducible by glucocorticoids in human liverMOLOWA, D. T; SCHUETZ, E. G; WRIGHTON, S. A et al.Proceedings of the National Academy of Sciences of the United States of America. 1986, Vol 83, Num 14, pp 5311-5315, issn 0027-8424Article